돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1409739생성일: 2026년 10월 25일

Tetrapropylammonium → 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-one

https://huagongshe.com/reaction/1409739

반응식

참여 물질

역할이름HCID투입량
반응물TetrapropylammoniumHCID 9559—
반응물Methyl morpholine oxideHCID 82029—
반응물1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-OLHCID 21897744—
용매DichloromethaneHCID 6344—
생성물1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-oneHCID 66915348—

반응 단계

1-[3-(Propan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-4-ol (0.5 g) is dissolved in dichloromethane (75 mL) and 4 A molecular sieves (4 g) are added followed by N-methylmorpholine-N-oxide (1.52 g) and tetrapropylammonium perrhutenate (0.018 g) and the mixture is stirred at room temperature for 1 h. The reaction is then filtered through celite and the mother liquor washed with water (2×50 mL). The water layers are then combined and back extracted with dichloroemthane (100 mL). The dichloromethane layers are combined, dried over Na2SO4, filtered and concentrated to give the title compound. LC (method 20): tR=1.67 min; Mass spectrum (APCI): m/z=210 [M+H]+.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08921398B2
출처 데이터셋uspto-grants-2014_12
ORD IDord-38fbc51127124e7badac6fcceb6e2ec6
출처 메모uspto-grants-2014_12